Jason Lettiere

Jason Lettiere's work experience began in 2009 as a Senior Analyst at Ipreo. Jason then moved into healthcare investment banking roles at Brocair Partners LLC in 2011 and Ferghana Partners in 2012. In 2014, they joined Intercept Pharmaceuticals as an Analyst in corporate strategy before transitioning to Manager and later Senior Manager positions in business development. Lettiere joined Bank of America Merrill Lynch in 2018 as part of the healthcare investment banking team. In 2019, they joined Neurogene Inc. as Executive Director of Business Development and later became the Executive Director of Corporate & Business Development. Their most recent position, starting in 2022, is as Vice President of Business Development at Terns Pharmaceuticals.

Jason Lettiere attended Bentley University from 2005 to 2009, where they obtained a B.S. degree in Economics & Finance. Jason also obtained certifications in Series 63 and Series 79 from the Financial Industry Regulatory Authority (FINRA). However, the specific dates of when they obtained these certifications are not provided.